Credit: BioNTechGerman biotech company BioNTech is sending a modular mRNA vaccine factory to Rwanda to allow the country to produce more COVID-19 shots for Africa, in Africa — and perhaps one day help the continent easily vaccinate its citizens against other deadly diseases, too.
The challenge: Africa manufactures less than 1% of the vaccines it uses, relying on other countries for the rest, and when the first COVID-19 vaccines were being made, wealthier countries scooped them up for their own citizens first, leaving Africans behind.
“The COVID-19 pandemic has exposed the need for significantly greater local production of vaccines.” TEDROS ADHANOM GHEBREYESUS
Even though many African nations are now well-supplied with COVID-19 shots, getting doses from manufacturing sites elsewhere in the world to Africa is a challenge — many shots require a cold chain, and the farther they need to be transported, the greater the chances of that chain breaking.
The idea: To increase vaccine production in Africa, Germany’s BioNTech — the company that designed one of the first mRNA COVID-19 vaccines with Pfizer — announced in February 2022 that it had designed a modular mRNA vaccine factory it dubbed a “BioNTainer. (See link for article)
Meanwhile the reality on the ground in Africa is quite different, where doctors have their eyes open, no one is getting tested or”vaccinated,” the use of ivermectin prolific, but there is no apparent COVID.
‘The powers that be’ are hell-bent on changing all of that under the banner of ‘equity.’
They simply can’t allow success using anything but what is in the accepted narrative.
Numerous African community groups are suing the government to stop the injections.
They don’t want equity. They want to live!
http:// (Approx. 8 Min)
FDA to propose yearly Covid vaccines like annual Flu shots — attempts to counter Vaccine Hesitancy
FDA scientists propose an annual Covid shot matched to current strains
By Matthew Herper Jan. 23, 2023
Scientists at the Food and Drug Administration propose making Covid vaccination a regular, once-a-year shot that is updated to match current strains of the SARS-CoV-2 virus, according to documents posted by the FDA on Monday. For people who are older or immunocompromised, the FDA would recommend two annual doses of the revised shot. (See link for article)
The FDA convenes expert committees to get guidance, but is not bound by their votes or recommendations. Still, it usually follows their advice.
The FDA has a history of not listening to committees, if it interferes with profits. If you believe the FDA is there to protect people, you are sadly mistaken. The agency is riddled with conflicts of interest and there is a revolving door between the agency and Big Pharma.
Recently the FDA chose to approve COVID boosters for all despite the advisory committee’s recommendation for them to be limited to those 65 and older. The FDA also allowed Moderna to omit important data suggesting the updated booster might not be any more effective at preventing infection than the original shots, which rightly has some members of the committee upset. For all intents and purposes it appears the COVID “vaccine” committee is purely for appearance only.
FDA gonna do what FDA gonna do.
Before reading the following article, remember the shenanigans public health “authorities” have been using to insist the clot shots are “safe and effective”:
- misleading surrogate endpoints for COVID shot trials such as reduction of symptoms, infections, hospitalizations, and even death rather than the proper end-point of severe morbidity
- the statistical trick of relative risk rather than absolute risk
- trial participants unblinding themselves
- the statistical trick of lowering the standard 50% threshold for blocking symptomatic infection
- delay tactics to release important data so the public can make informed consent
FDA wants to push a yearly shot on 6 year old girls & 20 year old men without RCTs proving reduction in severe disease
This Week’s Meeting Shows the Full Failure of this FDA
The FDA has posted briefing documents from VRBPAC— the vaccine advisory meeting coming this week. Conspicuously absent is information about subclinical myocarditis. Remember Pfizer was legally obligated to study troponin elevations in young men who got the shot. This is different than clinical myocarditis— this is heart damage that these young healthy men may not feel or may ignore, and is much more common.
To date, available data suggests it might be as much as 100 times more common (Thailand/ Swiss data). Yet strangely, these data are missing from the FDA briefing document. It’s sad the FDA once again neglects its duty to generate confirmatory data.
Instead we get this proposal for yearly shots: